VCIM
WVE icon

Velan Capital Investment Management’s Wave Life Sciences WVE Stock Holding History

Velan Capital Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$110K – 55
2025
Q3 		$110K Hold
15,000
– – 0.1% 41
2025
Q2 		$97.5K Buy
15,000
+2,000
+15% +$13.2K 0.1% 33
2025
Q1 		$105K Hold
13,000
– – 0.11% 30
2024
Q4 		$161K Buy
+13,000
New +$174K 0.14% 23

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Velan Capital Investment Management's WVE Position: Q4 2025 in Review

Velan Capital Investment Management sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 15,000 shares — an estimated $110K sold.

Velan Capital Investment Management first reported a position in WVE in Q4 2024 and held it in 4 quarters. The position peaked at $161K in Q4 2024. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Velan Capital Investment Management reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 15,000 Wave Life Sciences shares in Q4 2025, an estimated $110K.
  • Velan Capital Investment Management first reported a position in Wave Life Sciences in Q4 2024 and held it in 4 quarters.
  • Velan Capital Investment Management's Wave Life Sciences position peaked at $161K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Velan Capital Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.